StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) KPIs and segments

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.75−0.27 (-2.69%)

Close on Nov 16, 2026Market cap $645.19MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Bicara Therapeutics's business

Coming soon

This tab will track the numbers specific to Bicara Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?